Dimitri Prince

93 Flips | 7 Magazines | 1 Like | @DimitriPrince | Keep up with Dimitri Prince on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Dimitri Prince”

Merck's Keytruda misses the mark in second-line stomach cancer study

Merck’s Keytruda boasts an FDA approval in third-line stomach cancer, but its ambitions for moving earlier into treatment just took a hit.

Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval

For the second straight week, there’s a new psoriatic arthritis drug on the block. This week, that drug is Pfizer’s Xeljanz, which nabbed an FDA …

Akili to submit video game ADHD treatment for US approval in 2018

Follows trial suggesting attention benefits of its 'digital medicine' AKL-T01

Merck says it has restored most of its manufacturing hit by cyberattack

Six months after Merck & Co.'s manufacturing operations were crippled by a global cyberattack, the company says it has mostly recovered from the …

Novartis Announces Positive Data on Sickle Cell Disease Drug

<b>Novartis AG</b> NVS announced positive results from a post hoc subgroup analysis of the phase II study, SUSTAIN on pipeline candidate, crizanlizumab.<p>The …

Each new medicine costs £1.2bn to develop, up 70pc in just seven years

The cost of developing a cutting-edge medicine has jumped 70pc in just seven years to £1.2bn, a Deloitte study has found.<p>Yet a survey of the world’s top 12 drug firms by R&D spend found that despite spending more on each treatment, the companies were struggling to increase profits.<p>Deloitte’s …

Pfizer Launching 'Generic Viagra' Pills At Lower Price On Dec. 11

Pfizer Inc. has announced the launch of a "generic Viagra," which will come at half the price of the current erectile dysfunction drug available in …

#pharma

An exclusive analysis conducted by Talkwalker for PharmaTimes reveals which companies are the most successful at using social media and what they’re …

Patient Files: Rheumatoid arthritis

Philip Aherne was diagnosed with rheumatoid arthritis at the age of 22. Now 29, he talks to PharmaTimes about his life with the condition<p><b>What were</b> …

Novartis’ Kisqali shows PFS benefit in premenopausal breast cancer

Novartis has unveiled Phase III data showing that partnering Kisqali with an endocrine therapy significantly prolonged progression-free survival …

» NORGINE LAUNCHES PLENVU® (NER1006) IN THE UNITED KINGDOM

<b>CORPORATE MEDIA RELEASE</b><p><b>NORGINE LAUNCHES PLENVU® (NER1006) IN THE UNITED KINGDOM</b><p><b>First 1 litre PEG-based bowel preparation[1],[2],[3]</b>• <b><br>Superior</b> …

Lilly makes big push into devices to protect diabetes sales

Eli Lilly has unveiled its device-driven strategy for weathering the competitive and pricing pressures faced by its diabetes unit. The Big Pharma is …

Merck will delay filing Ebola vaccine for approval until 2018, company confirms

Despite a frantic effort to rush Ebola vaccines through testing during a deadly epidemic, Merck & Co. will fall short of its goal to file its …

Where Brexit Hurts: The Nurses and Doctors Leaving London

LONDON — Tanja Pardela is leaving London. Her last day is Nov. 26. She wells up talking about it. She will miss jacket potatoes, and Sunday roasts, and her morning commute — past playing fields, small children in school uniforms and a red telephone box — to the hospital where she has been a …

Great Britain

AIB must hand over account details in case alleging cyber fraud

Dutch pharma firm claims it lost almost €400,000 on back of fraudulent email<p>Wed, Dec 6, 2017, 17:44<p>A Dutch pharmaceutical company which claims it is …

As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report

Johnson & Johnson’s blockbuster anti-TNF drug Remicade fell victim to biosimilar competition in Europe in 2015 and in the U.S. last year, but the …

This Company Is About to Flood the U.S. With Cheap HIV Drugs

Among the coconut plantations and beaches of South India, a factory the size of 35 football fields is preparing to churn out billions of generic …

5 Digital Health Innovation Trends That Will Matter in 2018

In December 2016, many were suggesting that wearables were dead. Fitbit’s stock price was rapidly dropping. Apple Watch sales had declined for two …

Social Articles Tracking & PR news.com

A new report titled Global Light Field Market Research Report 2018 has been added to the database of Trusted Business Insights (TBI). In this report …

How Digital Marketing Is Becoming The New Pharma Sales Rep

The days of in-person sales calls and free lunch seminars from pharma reps have been waning for some time now. An annual study from CMI/Compas showed …

Novartis looks at offloading its generic pills business in U.S. as market continues to decline

The market for generic pills has gotten so bad in the U.S. that Novartis is thinking about selling off its oral solids business there, outgoing CEO …

The Wonder Drug for Aging (Made From One of the Deadliest Toxins on Earth)

There’s no easy way into Allergan’s Botox laboratories in Irvine, Calif. And once you’re inside there’s no quick way out. But first things first: …

Apple's future in healthcare: What we know (and can guess)

Apple has shown clear interest in the healthcare space this year, and is poised for a big 2018 in the market. Whether the IT giant will really be …

Novartis says Cosentyx effective for nail, palmoplantar psoriasis

Novartis says Cosentyx is the first biologic to show long-term efficacy in nail and palmoplantar psoriasis, which can impact up to 90 percent of …

The very real online threat to the pharma industry

The pharmaceutical industry is certainly not immune to cyber-crime. The ‘Petya’ cyber-attack that spread from the Ukrainian National Bank through to …

Novartis 'clearly' plans to hang on to GSK consumer stake: analyst

Novartis has the option to sell its stake in its GlaxoSmithKline consumer health JV to its partner. But it doesn’t sound like that’s what the Swiss …

Novartis to buy French nuclear medicine group AAA | Financial Times

Switzerland’s Novartis has agreed to pay $3.9bn to take over French nuclear medicines business Advanced Accelerator Applications in the Swiss group’s …

biotechdlda

One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology

Novartis heart failure med Entresto, which got a slow start after launching to multibillion-dollar sales expectations, would have seen faster uptake, …

Market Realist

Our website is made possible by displaying online advertisements to our visitors.<br>Please consider supporting us by disabling your ad blocker.

Trading Strategies For Pharma Giants Merck And Pfizer

Merck, a pharmaceutical giant and component of the Dow Jones Industrial Average<b>,</b> reported quarterly earnings before the open on Friday and gapped lower on Friday, and again today. From its close of $61.99 on Thursday to its open on Monday of $55.75 the stock crashed by 10%, which set this stock to …